| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 97.77B | 97.10B | 95.15B | 89.25B | 76.18B | 76.25B |
| Gross Profit | 23.65B | 23.44B | 22.61B | 17.96B | 16.38B | 17.34B |
| EBITDA | 9.14B | 8.95B | 7.52B | 6.31B | 4.14B | 5.86B |
| Net Income | 3.51B | 3.50B | 2.41B | 1.32B | -658.00M | 482.00M |
Balance Sheet | ||||||
| Total Assets | 93.78B | 100.51B | 95.64B | 93.27B | 91.22B | 90.99B |
| Cash, Cash Equivalents and Short-Term Investments | 12.48B | 14.10B | 10.85B | 13.78B | 15.40B | 17.22B |
| Total Debt | 7.15B | 9.07B | 7.21B | 7.02B | 8.54B | 8.42B |
| Total Liabilities | 31.80B | 37.17B | 33.10B | 34.63B | 33.61B | 32.10B |
| Stockholders Equity | 51.20B | 52.62B | 50.08B | 46.40B | 45.75B | 47.12B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 4.43B | 2.64B | -1.39B | 1.72B | 8.82B |
| Operating Cash Flow | 0.00 | 6.89B | 4.19B | 260.00M | 4.42B | 10.50B |
| Investing Cash Flow | 0.00 | -1.23B | -2.90B | 1.35B | -1.22B | -1.19B |
| Financing Cash Flow | 0.00 | -3.03B | -2.99B | -5.07B | -2.93B | -6.94B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
81 Outperform | ¥663.65B | 26.71 | 13.15% | 0.23% | 2.66% | 7.90% | |
78 Outperform | ¥679.46B | 15.50 | 8.07% | 2.85% | 11.18% | -0.75% | |
72 Outperform | ¥77.53B | -34.71 | ― | 2.36% | 2.78% | 127.66% | |
70 Outperform | ¥35.10B | 10.46 | ― | 4.53% | -2.57% | 3.43% | |
70 Outperform | ¥77.45B | 10.57 | ― | 3.05% | 10.79% | 12.28% | |
64 Neutral | ¥154.35B | 29.59 | 5.91% | 2.39% | -3.24% | -25.21% | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% |